5021Healthy and sustainable diets: key workstreams in the WHO European Region: factsheet 2021Technical Documents · March 23, 2021
5022A guide to establishing national public health institutes through mergersTechnical Documents · March 23, 2021
5023COVID-19 : santé et sécurité au travail pour les agents de santé : orientations provisoires, 2 février 2021Technical Documents · March 23, 2021
5024Evaluation of COVID-19 vaccine effectiveness: interim guidance, 17 March 2021Technical Documents · March 23, 2021
5026Sample size calculator for evaluation of COVID-19 vaccine effectiveness, 17 March 2021Technical Documents · March 23, 2021
5027Necesidades, percepciones y demandas de las comunidades: instrumento de evaluación comunitaria: módulo de la serie de evaluaciones de la capacidad de los servicios de salud en el contexto de la pandemia de COVID-19: orientaciones provisionales, 5 de febrero de 2021Technical Documents · March 23, 2021
5028Job aid for COVID-19 vaccine administration: Moderna COVID-19 (mRNA-1273) vaccine, June 2021Technical Documents · March 22, 2021
5029Job aid for COVID-19 vaccine administration: AZD1222 (ChAdOx1-S [recombinant]) COVID-19 vaccine, March 2021Technical Documents · March 22, 2021
5031Туберкулез в Европейском регионе ВОЗ: информационный бюллетеньTechnical Documents · March 22, 2021
5032Cohort study to measure COVID-19 vaccine effectiveness among health workers in the WHO European Region: guidance documentTechnical Documents · March 18, 2021
5033Аспекты работы системы здравоохранения в условиях одновременной циркуляции гриппа и COVID-19: меры готовности и реагирования в связи с одновременной циркуляцией COVID-19, гриппа и острых респираторных инфекций в Европейском регионе ВОЗ. Обновленная версия Декабрь 2020 г.Technical Documents · March 18, 2021
5034Supporting the mental health and well-being of the health and care workforceTechnical Documents · March 18, 2021
5035Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine: interim guidance, 17 March 2021Technical Documents · March 17, 2021
5037Background document on the Janssen Ad26.COV2.S (COVID-19) vaccine: background document to the WHO Interim recommendations for use of Ad26.COV2.S (COVID-19) vaccine, 17 March 2021Technical Documents · March 16, 2021
5038Acceptance of available traditional vaccine supply with reduced shelf-life: interim guidance, 1 March 2021Technical Documents · March 15, 2021
5039Vacunación frente a la COVID 19: guía de suministro y logística: orientación provisional, 12 febrero de 2021Technical Documents · March 12, 2021
5040COVID-19 strategic preparedness and response plan: 1 February 2021 to 31 January 2022Technical Documents · March 11, 2021